Shares of Amgen Inc. (NASDAQ:AMGN – Get Free Report) have earned a consensus recommendation of “Hold” from the twenty-four ...

Amgen (AMGN) ended the recent trading session at $314.38, demonstrating a -0.53% swing from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of 1.77%.

The Dow Jones Industrial Average (DJINDICES: ^DJI) has changed a lot in recent years. In 2020, Salesforce, Amgen, and ...

Merck & Co. will pay as much as $2 billion for the rights to Jiangsu Hengrui Pharmaceuticals Co.’s experimental heart drug, ...

Scientists at deCODE genetics, a subsidiary of Amgen, reveal today in Nature Genetics associations between bipolar disorder and rare loss-of-function ...

ILMN and Nashville Biosciences, LLC (NashBio) recently announced that 250,000 whole genomes have been sequenced for the Alliance for Genomic Discovery (AGD) initiative. The insights from the AGD ...

SCHD's Index reconstituted at the close of business Friday, resulting in 20 additions and 17 deletions. See why I rate the ...

Diality Inc., a medical device company that has developed the Moda-flx Hemodialysis Systemtm, today announced the addition of Dr. Chris Springer to its board of directors. Dr. Springer brings 30 years ...

Blueshift Asset Management has taken a $345,000 plunge into Amgen, joining a biotech investor pool that's as crowded as a ...

After every meal, the intestines perform an action called peristalsis — moving food through their hollow interiors with coordinated contractions and ...

The company expects next quarter to read out initial data from its Heart-2 trial, which is testing a one-time treatment for people with genetically elevated cholesterol.

The global axial spondyloarthritis market is set for significant growth, with forecasts indicating a robust CAGR of 14.8% during the period from 2022 to 2028. This growth is primarily attributed to ...